Polarean Imaging to Announce 2024 Financial Results on May 8

Polarean Imaging ( (GB:POLX) ) has provided an update.

Polarean Imaging PLC has announced that it will release its full-year financial results for 2024 on May 8, 2025. The company’s CEO, Christopher von Jako, and CFO, Charles Osborne, will host a live online presentation to discuss the results, open to all shareholders and interested parties. This announcement highlights Polarean’s commitment to transparency and engagement with its stakeholders, as it continues to advance its position in the medical imaging industry.

More about Polarean Imaging

Polarean Imaging is a medical imaging technology company focused on revolutionizing pulmonary medicine by providing advanced MRI solutions for lung function visualization. The company is a leader in hyperpolarization science and has developed the FDA-approved hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW®. Polarean’s platform offers non-invasive, radiation-free imaging solutions to address the needs of over 500 million patients with chronic respiratory diseases worldwide. Established in 2012, Polarean operates from offices in Durham, NC, and London, UK.

YTD Price Performance: -45.00%

Average Trading Volume: 22,625

Technical Sentiment Signal: Buy

Current Market Cap: $16.43M

Learn more about POLX stock on TipRanks’ Stock Analysis page.